Full Text View
Tabular View
No Study Results Posted
Related Studies
Anidulafungin in Treating Immunocompromised Children With Neutropenia
This study has been completed.
Study NCT00068471   Information provided by National Cancer Institute (NCI)
First Received: September 10, 2003   Last Updated: May 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infection
Neutropenia
Additional conditions recognized in this trial
Communicable Diseases
More general conditions related to this trial
Agranulocytosis
Hematologic Diseases
Leukocyte Disorders
Leukopenia
Interventions listed in this trial
anidulafungin
Additional drug interventions recognized in this trial
Echinocandins
More general drug interventions related to this trial
Anti-Infective Agents
Antibiotics, Antifungal
Antifungal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services